Millaray Marincevic

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer.

Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer.

Journal: Journal for immunotherapy of cancer

Published: August 01, 2025

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia.

Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia.

Journal: Blood neoplasia

Published: October 21, 2024

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients.

LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: May 01, 2022

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting.

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting.

Journal: Leukemia

Published: June 29, 2020

Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Journal: Leukemia

Published: December 12, 2019

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Journal: Leukemia

Published: September 04, 2018

Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression.

Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression.

Journal: Cancer letters

Published: August 14, 2014

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

Journal: International journal of cancer

Published: October 11, 2013

Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.

Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.

Journal: Epigenetics

Published: November 17, 2012

Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.

Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.

Journal: American journal of hematology

Published: December 30, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026